Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
FOCUS
|
PRO
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
-
-
-
Pacira Could Be The Next Pharma Stock You Wished You OwnedFreedonia Freelance • Thu, Dec 6, 2012 -
-
Pacira Pharmaceuticals Has Great PotentialRoy Manning III • Thu, May 3, 2012 -
-
-
-
Pacira Pharmaceuticals Prices IPO Below RangeSA Editor Mohit Manghnani • Fri, Feb 4, 2011
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
5 Highly Shorted Small-Caps With Strong Insider And Institutional BuyingKapitall • Tue, Sep 18, 2012 -
-
-
3 Highly Liquid Small Caps Rated 'Strong Buy'ZetaKap • Wed, Aug 22, 2012 -
-
3 Pharmaceutical Stocks Armed With Cash And Analyst BackingZetaKap • Wed, Jul 11, 2012
-
Insiders Love These 10 Outperforming Healthcare StocksKapitall • Tue, Jul 10, 2012
-
3 Rallying Drug-Makers Being Snapped Up By InsidersKapitall • Fri, Jun 22, 2012
-
-
-
10 Stocks Favored By Hedge Funds And Company InsidersKapitall • Fri, May 25, 2012
-
-
-
6 Outperforming Healthcare Stocks Being Snapped Up By InsidersKapitall • Sun, Apr 22, 2012
-
-
Major Corporate Insider And Institutional SEC Filings This WeekGuruFundPicks • Wed, Apr 18, 2012
-
Business Wire (May 28, 2013)
-
Business Wire (May 8, 2013)
-
Business Wire (Apr 12, 2013)
-
Business Wire (Apr 5, 2013)
-
at CNBC.com (Mar 13, 2013)
-
Business Wire (Mar 7, 2013)
-
Business Wire (Mar 6, 2013)
-
Pacira Pharmaceuticals, Inc. Announces Timing for 2012 Financial Results Webcast and Conference CallBusiness Wire (Feb 28, 2013)
-
Business Wire (Feb 25, 2013)
-
Business Wire (Jan 17, 2013)
-
Pacira Pharmaceuticals, Inc. Announces Proposed Offering of $100 Million of Convertible Senior NotesBusiness Wire (Jan 15, 2013)
PCRX vs. ETF Alternatives
Company Description
Currently, there's no company description for PCRX.
